Brief: Mira Pharmaceuticals Inc DEA Rules Mira-55, A Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified As A Controlled Substance
29/05/2024 13:57
May 29 (Reuters) - Mira Pharmaceuticals Inc MIRA.O :
* MIRA PHARMACEUTICALS INC: DEA RULES MIRA-55, A NOVEL ORAL
PHARMACEUTICAL MARIJUANA ANALOG, IS NOT CLASSIFIED AS A
CONTROLLED SUBSTANCE
Source text for Eikon: ID:nPn8GgnKka
Further company coverage: MIRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mira Pharmaceuticals
See all newsBrief: Mira Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
Brief: MIRA Pharmaceuticals Secures Worldwide Exclusive Rights To MIRA-55 And SKNY-1 - SEC Filing
Brief: Mira Pharmaceuticals Enters Into Amendment No 1 To Exclusive License Agreement With Miralogx
Brief: Mira Pharmaceuticals Inc - Completes Phase 1 Dosing Of Ketamir-2 - SEC Filing
Brief: Mira Pharmaceuticals Inc - Initiates Phase 1 Study Of Ketamir-2 - SEC Filing